🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase I trial studies the side effects and best dose of stereotactic b...
Status
Completed
Location
University of Wisconsin Carbone Cancer Center
Start Date
2014-04-08
Trial ID
NCT01918644
This is a phase I, multicenter, open-label study starting with a dose explo...
Status
Active Not Recruiting
Location
Institut Bergonié
Start Date
2023-12-12
Trial ID
NCT05821231
Treatments Being Tested
The purpose of this study is to demonstrate that combined stereotactic body...
Status
Completed
Location
UCLA Jonsson Comprehensive Cancer Center
Start Date
2010-02-08
Trial ID
NCT01051037
Treatments Being Tested
This phase II trial tests the effectiveness and safety of artificial intell...
Status
Recruiting
Location
Northwestern University
Start Date
2023-11-20
Trial ID
NCT05802186
Pancreatic cancer, most commonly adenocarcinoma, is the fourth leading caus...
Status
Active Not Recruiting
Location
University of Nebraska Medical Center
Start Date
2016-09-16
Trial ID
NCT03073785
This is a research study of a radiation treatment called stereotactic body ...
Status
Withdrawn
Location
Indiana University
Start Date
2012-02
Trial ID
NCT01801163
Treatments Being Tested
This phase II trial studies how well stereotactic body radiotherapy and ipi...
Status
Terminated
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2014-03
Trial ID
NCT01970527
RATIONALE: Stereotactic body radiation therapy may be able to send x-rays d...
Status
Completed
Location
University of Texas Southwestern Medical Center - Dallas
Start Date
2009-02
Trial ID
NCT00855803
Treatments Being Tested
The purpose of this study is to investigate the safety and effects of IMM 1...
Status
Completed
Location
HCA International, The Sarah Cannon Research Institute
Start Date
2012-05-30
Trial ID
NCT01539824
Treatments Being Tested
Durvalumab is a drug that stimulates the immune system to fight lung cancer...
Status
Completed
Location
Rhode Island Hospital
Start Date
2019-05-13
Trial ID
NCT03589547
Treatments Being Tested